SUBSCRIBE
SUBSCRIBE
News   Drug Development

UK Body Backs Limited Use of Eli Lilly and Company (JOBS), Daiichi Sankyo Co Ltd. Anti-Clot Drug

September 4, 2009 | 
1 min read
Bookmark and Share

Reuters -- Eli Lilly and Daiichi Sankyo's anti-clotting drug prasugrel has been recommended for limited use on Britain's state-run National Health Service.
Clinical research Postmarket research Europe
Eli Lilly and Company Daiichi Sankyo
MORE ON THIS TOPIC
Painful female periods concept. Vector flat character illustration. Woman standing and suffering menstrual abdominal pain isolated on pink background. Design for health care.
Women’s Health
Organon’s Endometriosis Drug Discontinued After Failing To Improve Pain
July 2, 2025
 · 
1 min read
 · 
Annalee Armstrong
IN PARTNERSHIP WITH IQVIA
Understanding the FDA’s AI Guidance in Pharmacovigilance
July 1, 2025
 · 
1 min read
 · 
Lori Ellis
Hand holding a nasal spray bottle against a white background
Psychedelics
Beckley’s Psychedelic Nasal Spray Clears Phase II Depression Study
July 1, 2025
 · 
2 min read
 · 
Tristan Manalac
Collage with halftone hands putting puzzle together. Teamwork concept vector pop art retro style illustration. Partnership and relationship design element for infographic, poster, website
Rare diseases
FDA Signs Off on Neurogene’s ‘Best-Case Scenario’ Pivotal Study Design for Rett Syndrome
July 1, 2025
 · 
2 min read
 · 
Tristan Manalac